Clinical Trial: A Study to Assess the Safety and Effects of the Investigational Drug BW-40202 in Healthy Volunteers

U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT06917482) titled 'A Study to Assess the Safety and Effects of the Investigational Drug BW-40202 in Healthy Volunteers' on March 10.

Brief Summary: This study will test the safety of a new drug called BW-40202 in healthy adults. The drug is a clear liquid given as an injection under the skin (subcutaneous injection). The study will test five different doses of BW-40202 compared to a placebo (saltwater solution).

Participants will be divided into five groups, with each group receiving a different dose of BW-40202 or placebo. In each group, eight people will be randomly assigned to receive either the drug (6 people) or placebo (2 people).

The Safety R...